PTC Withdraws Translarna US FDA Filing

 
• By Joseph Haas
  
PTC is withdrawing its Translarna NDA, ending a 12-year effort to gain US approval. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from US FDA Performance Tracker